Design Therapeutics, Inc. (DSGN): Price and Financial Metrics
DSGN Price/Volume Stats
| Current price | $4.00 | 52-week high | $7.77 |
| Prev. close | $4.10 | 52-week low | $2.60 |
| Day low | $3.87 | Volume | 63,400 |
| Day high | $4.22 | Avg. volume | 147,311 |
| 50-day MA | $3.74 | Dividend yield | N/A |
| 200-day MA | $4.92 | Market Cap | 227.08M |
DSGN Stock Price Chart Interactive Chart >
Design Therapeutics, Inc. (DSGN) Company Bio
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
DSGN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DSGN Price Returns
| 1-mo | 20.12% |
| 3-mo | -18.70% |
| 6-mo | -37.60% |
| 1-year | -2.20% |
| 3-year | -73.03% |
| 5-year | N/A |
| YTD | -35.17% |
| 2024 | 132.83% |
| 2023 | -74.17% |
| 2022 | -52.08% |
| 2021 | N/A |
| 2020 | N/A |